文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血液制品输注对脓毒性休克患者ICU获得性感染风险的影响

Impact of Blood Product Transfusions on the Risk of ICU-Acquired Infections in Septic Shock.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论脓毒性休克存活48小时以上的患者中,输注血小板和新鲜冰冻血浆与后续ICU获得性感染独立相关。

该单中心回顾性研究纳入2008-2017年ICU入住48小时内诊断脓毒性休克且存活超过48小时的893例患者,探讨血液制品输注与ICU获得性感染的关系。结果显示28.3%的患者发生首次ICU获得性感染,以肺部感染为主(57%)。提示在脓毒性休克恢复期患者中,应审慎评估血小板和血浆输注指征,并将ICU获得性感染作为未来输血研究的相关终点。

要点

  • 脓毒性休克存活48小时以上的患者中,28.3%发生首次ICU获得性感染,其中肺部感染占57%。
  • 发生ICU获得性感染的患者更可能接受过红细胞、血小板和新鲜冰冻血浆输注。
  • 研究建议将ICU获得性感染作为未来输血指征研究的相关终点。

适用人群与场景

  • 纳入:ICU入住48小时内诊断脓毒性休克、且ICU管理48小时后仍存活的患者(单中心医疗ICU,2008-2017年连续病例)。
  • 排除:ICU入住48小时内出院或死亡的患者。
  • 场景:三级医疗中心ICU,病情阶段为脓毒性休克初始复苏后存活超过48小时。

诊断标准与关键阈值

  • 脓毒性休克诊断:原文未提及具体诊断标准。
  • ICU获得性感染:原文未提及具体诊断标准,仅报告首次发作时间及感染部位分布(肺部感染占57%)。
  • 输血暴露窗口:ICU获得性感染发病前24小时内的红细胞、血小板和新鲜冰冻血浆输注。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:单中心回顾性研究,10年期间(2008-2017年),三级医疗中心医疗ICU。
  • 样本量:1152例因脓毒性休克入住ICU,893例在ICU管理48小时后仍存活纳入分析。
  • 主要终点:首次ICU获得性感染发生于48小时存活者的28.3%,以肺部感染为主(57%)。
  • 描述性比较:发生ICU获得性感染的患者更可能接受过红细胞、血小板和新鲜冰冻血浆输注。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心、回顾性设计;仅纳入存活超过48小时的患者;输血为感染前24小时内暴露;观察性设计不能排除混杂。

对床旁实践的改变

  • 在脓毒性休克恢复期(存活超过48小时)患者中,应审慎评估血小板和新鲜冰冻血浆的输注指征,因二者与后续ICU获得性感染独立相关。
  • 该研究为观察性设计,不能确立因果关系,不能据此更改输血阈值,但提示临床医生在考虑血小板或血浆输注时应权衡感染风险。
  • 原文建议将ICU获得性感染作为未来输血指征研究的相关终点。

指南或共识出处

  • Crit Care Med

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Transfusions of blood products are common in critically ill patients and have a potential for immunomodulation. The aim of this study is to address the impact of transfusion of blood products on the susceptibility to ICU-acquired infections in the high-risk patients with septic shock.

DESIGN: A single-center retrospective study over a 10-year period (2008-2017).

SETTING: A medical ICU of a tertiary-care center.

PATIENTS: All consecutive patients diagnosed for septic shock within the first 48 hours of ICU admission were included. Patients who were discharged or died within the first 48 hours were excluded.

INTERVENTIONS: RBC, platelet, and fresh frozen plasma transfusions collected up to 24 hours prior to the onset of ICU-acquired infection.

MEASUREMENTS AND MAIN RESULTS: During the study period, 1,152 patients were admitted for septic shock, with 893 patients remaining alive in the ICU after 48 hours of management. A first episode of ICU-acquired infection occurred in 28.3% of the 48-hour survivors, with a predominance of pulmonary infections (57%). Patients with ICU-acquired infections were more likely to have received RBC, platelet, and fresh frozen plasma transfusions. In a multivariate Cox cause-specific analysis, transfusions of platelets (cause-specific hazard ratio = 1.55 [1.09-2.20]; p = 0.01) and fresh frozen plasma (cause-specific hazard ratio = 1.38 [0.98-1.92]; p = 0.05) were independently associated with the further occurrence of ICU-acquired infections.

CONCLUSIONS: Transfusions of platelets and fresh frozen plasma account for risk factors of ICU-acquired infections in patients recovering from septic shock. The occurrence of ICU-acquired infections should be considered as a relevant endpoint in future studies addressing the indications of transfusions in critically ill patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Péju E, Llitjos JF, Charpentier J, et al. Impact of Blood Product Transfusions on the Risk of ICU-Acquired Infections in Septic Shock. Crit Care Med. 2021. PMID: 33591005. doi:10.1097/CCM.0000000000004887

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。